LDHA and non-small cell lung carcinoma: In a phase‐2b clinical trial, ALDH serves as an antioxidative stress mechanism, and the treatment with an ALDH inhibitor combined with disulfiram and cisplatin‐based chemotherapy achieves enhanced survival of advanced NSCLC patients.288